0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anticoagulant Reversal Drug Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-27M7053
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anticoagulant Reversal Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Anticoagulant Reversal Drug Market Research Report 2024

Code: QYRE-Auto-27M7053
Report
February 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anticoagulant Reversal Drug Market Size

The global Anticoagulant Reversal Drug market was valued at US$ 1444.8 million in 2023 and is anticipated to reach US$ 2259.5 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Anticoagulant Reversal Drug Market

Anticoagulant Reversal Drug Market

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anticoagulant Reversal Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant Reversal Drug.

Report Scope

The Anticoagulant Reversal Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticoagulant Reversal Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticoagulant Reversal Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anticoagulant Reversal Drug Market Report

Report Metric Details
Report Name Anticoagulant Reversal Drug Market
Accounted market size in 2023 US$ 1444.8 million
Forecasted market size in 2030 US$ 2259.5 million
CAGR 6.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bausch Health Companies, Pfizer, Fresenius Kabi, Amneal Pharmaceuticals, Boehringer Ingelheim, CSL, Octapharma, Portola Pharmaceuticals, Perosphere Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anticoagulant Reversal Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anticoagulant Reversal Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Anticoagulant Reversal Drug Market growing?

Ans: The Anticoagulant Reversal Drug Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Anticoagulant Reversal Drug Market size in 2030?

Ans: The Anticoagulant Reversal Drug Market size in 2030 will be US$ 2259.5 million.

Who are the main players in the Anticoagulant Reversal Drug Market report?

Ans: The main players in the Anticoagulant Reversal Drug Market are Bausch Health Companies, Pfizer, Fresenius Kabi, Amneal Pharmaceuticals, Boehringer Ingelheim, CSL, Octapharma, Portola Pharmaceuticals, Perosphere Pharmaceuticals

What are the Application segmentation covered in the Anticoagulant Reversal Drug Market report?

Ans: The Applications covered in the Anticoagulant Reversal Drug Market report are Hospital Pharmacies, Retail Pharmacies, Others

What are the Type segmentation covered in the Anticoagulant Reversal Drug Market report?

Ans: The Types covered in the Anticoagulant Reversal Drug Market report are Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid

1 Anticoagulant Reversal Drug Market Overview
1.1 Product Overview and Scope of Anticoagulant Reversal Drug
1.2 Anticoagulant Reversal Drug Segment by Type
1.2.1 Global Anticoagulant Reversal Drug Market Value Comparison by Type (2024-2030)
1.2.2 Prothrombin Complex Concentrates
1.2.3 Vitamin K
1.2.4 Protamine
1.2.5 Tranexamic Acid
1.3 Anticoagulant Reversal Drug Segment by Application
1.3.1 Global Anticoagulant Reversal Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Global Anticoagulant Reversal Drug Market Size Estimates and Forecasts
1.4.1 Global Anticoagulant Reversal Drug Revenue 2019-2030
1.4.2 Global Anticoagulant Reversal Drug Sales 2019-2030
1.4.3 Global Anticoagulant Reversal Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anticoagulant Reversal Drug Market Competition by Manufacturers
2.1 Global Anticoagulant Reversal Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anticoagulant Reversal Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anticoagulant Reversal Drug Average Price by Manufacturers (2019-2024)
2.4 Global Anticoagulant Reversal Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anticoagulant Reversal Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anticoagulant Reversal Drug, Product Type & Application
2.7 Anticoagulant Reversal Drug Market Competitive Situation and Trends
2.7.1 Anticoagulant Reversal Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anticoagulant Reversal Drug Players Market Share by Revenue
2.7.3 Global Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anticoagulant Reversal Drug Retrospective Market Scenario by Region
3.1 Global Anticoagulant Reversal Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anticoagulant Reversal Drug Global Anticoagulant Reversal Drug Sales by Region: 2019-2030
3.2.1 Global Anticoagulant Reversal Drug Sales by Region: 2019-2024
3.2.2 Global Anticoagulant Reversal Drug Sales by Region: 2025-2030
3.3 Global Anticoagulant Reversal Drug Global Anticoagulant Reversal Drug Revenue by Region: 2019-2030
3.3.1 Global Anticoagulant Reversal Drug Revenue by Region: 2019-2024
3.3.2 Global Anticoagulant Reversal Drug Revenue by Region: 2025-2030
3.4 North America Anticoagulant Reversal Drug Market Facts & Figures by Country
3.4.1 North America Anticoagulant Reversal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anticoagulant Reversal Drug Sales by Country (2019-2030)
3.4.3 North America Anticoagulant Reversal Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anticoagulant Reversal Drug Market Facts & Figures by Country
3.5.1 Europe Anticoagulant Reversal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anticoagulant Reversal Drug Sales by Country (2019-2030)
3.5.3 Europe Anticoagulant Reversal Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anticoagulant Reversal Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Anticoagulant Reversal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anticoagulant Reversal Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Anticoagulant Reversal Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anticoagulant Reversal Drug Market Facts & Figures by Country
3.7.1 Latin America Anticoagulant Reversal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anticoagulant Reversal Drug Sales by Country (2019-2030)
3.7.3 Latin America Anticoagulant Reversal Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anticoagulant Reversal Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Anticoagulant Reversal Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anticoagulant Reversal Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anticoagulant Reversal Drug Sales by Type (2019-2030)
4.1.1 Global Anticoagulant Reversal Drug Sales by Type (2019-2024)
4.1.2 Global Anticoagulant Reversal Drug Sales by Type (2025-2030)
4.1.3 Global Anticoagulant Reversal Drug Sales Market Share by Type (2019-2030)
4.2 Global Anticoagulant Reversal Drug Revenue by Type (2019-2030)
4.2.1 Global Anticoagulant Reversal Drug Revenue by Type (2019-2024)
4.2.2 Global Anticoagulant Reversal Drug Revenue by Type (2025-2030)
4.2.3 Global Anticoagulant Reversal Drug Revenue Market Share by Type (2019-2030)
4.3 Global Anticoagulant Reversal Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anticoagulant Reversal Drug Sales by Application (2019-2030)
5.1.1 Global Anticoagulant Reversal Drug Sales by Application (2019-2024)
5.1.2 Global Anticoagulant Reversal Drug Sales by Application (2025-2030)
5.1.3 Global Anticoagulant Reversal Drug Sales Market Share by Application (2019-2030)
5.2 Global Anticoagulant Reversal Drug Revenue by Application (2019-2030)
5.2.1 Global Anticoagulant Reversal Drug Revenue by Application (2019-2024)
5.2.2 Global Anticoagulant Reversal Drug Revenue by Application (2025-2030)
5.2.3 Global Anticoagulant Reversal Drug Revenue Market Share by Application (2019-2030)
5.3 Global Anticoagulant Reversal Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bausch Health Companies
6.1.1 Bausch Health Companies Corporation Information
6.1.2 Bausch Health Companies Description and Business Overview
6.1.3 Bausch Health Companies Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bausch Health Companies Anticoagulant Reversal Drug Product Portfolio
6.1.5 Bausch Health Companies Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Anticoagulant Reversal Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Anticoagulant Reversal Drug Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Anticoagulant Reversal Drug Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Anticoagulant Reversal Drug Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Anticoagulant Reversal Drug Product Portfolio
6.7.5 Octapharma Recent Developments/Updates
6.8 Portola Pharmaceuticals
6.8.1 Portola Pharmaceuticals Corporation Information
6.8.2 Portola Pharmaceuticals Description and Business Overview
6.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Portola Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
6.8.5 Portola Pharmaceuticals Recent Developments/Updates
6.9 Perosphere Pharmaceuticals
6.9.1 Perosphere Pharmaceuticals Corporation Information
6.9.2 Perosphere Pharmaceuticals Description and Business Overview
6.9.3 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product Portfolio
6.9.5 Perosphere Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anticoagulant Reversal Drug Industry Chain Analysis
7.2 Anticoagulant Reversal Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anticoagulant Reversal Drug Production Mode & Process
7.4 Anticoagulant Reversal Drug Sales and Marketing
7.4.1 Anticoagulant Reversal Drug Sales Channels
7.4.2 Anticoagulant Reversal Drug Distributors
7.5 Anticoagulant Reversal Drug Customers
8 Anticoagulant Reversal Drug Market Dynamics
8.1 Anticoagulant Reversal Drug Industry Trends
8.2 Anticoagulant Reversal Drug Market Drivers
8.3 Anticoagulant Reversal Drug Market Challenges
8.4 Anticoagulant Reversal Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Anticoagulant Reversal Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anticoagulant Reversal Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anticoagulant Reversal Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anticoagulant Reversal Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Anticoagulant Reversal Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anticoagulant Reversal Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anticoagulant Reversal Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anticoagulant Reversal Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anticoagulant Reversal Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anticoagulant Reversal Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anticoagulant Reversal Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Anticoagulant Reversal Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anticoagulant Reversal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Reversal Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anticoagulant Reversal Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anticoagulant Reversal Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Anticoagulant Reversal Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Anticoagulant Reversal Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Anticoagulant Reversal Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Anticoagulant Reversal Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anticoagulant Reversal Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Anticoagulant Reversal Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anticoagulant Reversal Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Anticoagulant Reversal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anticoagulant Reversal Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Anticoagulant Reversal Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Anticoagulant Reversal Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anticoagulant Reversal Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anticoagulant Reversal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anticoagulant Reversal Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Anticoagulant Reversal Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Anticoagulant Reversal Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anticoagulant Reversal Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anticoagulant Reversal Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anticoagulant Reversal Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Anticoagulant Reversal Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Anticoagulant Reversal Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anticoagulant Reversal Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anticoagulant Reversal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anticoagulant Reversal Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Anticoagulant Reversal Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Anticoagulant Reversal Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anticoagulant Reversal Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anticoagulant Reversal Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anticoagulant Reversal Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Anticoagulant Reversal Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Anticoagulant Reversal Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anticoagulant Reversal Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anticoagulant Reversal Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Anticoagulant Reversal Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Anticoagulant Reversal Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Anticoagulant Reversal Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Anticoagulant Reversal Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anticoagulant Reversal Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anticoagulant Reversal Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Anticoagulant Reversal Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Anticoagulant Reversal Drug Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Anticoagulant Reversal Drug Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Anticoagulant Reversal Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Anticoagulant Reversal Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Anticoagulant Reversal Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Anticoagulant Reversal Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Anticoagulant Reversal Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anticoagulant Reversal Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anticoagulant Reversal Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Anticoagulant Reversal Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Anticoagulant Reversal Drug Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Anticoagulant Reversal Drug Price (USD/Unit) by Application (2025-2030)
    Table 70. Bausch Health Companies Corporation Information
    Table 71. Bausch Health Companies Description and Business Overview
    Table 72. Bausch Health Companies Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Bausch Health Companies Anticoagulant Reversal Drug Product
    Table 74. Bausch Health Companies Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Pfizer Anticoagulant Reversal Drug Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Fresenius Kabi Corporation Information
    Table 81. Fresenius Kabi Description and Business Overview
    Table 82. Fresenius Kabi Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Fresenius Kabi Anticoagulant Reversal Drug Product
    Table 84. Fresenius Kabi Recent Developments/Updates
    Table 85. Amneal Pharmaceuticals Corporation Information
    Table 86. Amneal Pharmaceuticals Description and Business Overview
    Table 87. Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Amneal Pharmaceuticals Anticoagulant Reversal Drug Product
    Table 89. Amneal Pharmaceuticals Recent Developments/Updates
    Table 90. Boehringer Ingelheim Corporation Information
    Table 91. Boehringer Ingelheim Description and Business Overview
    Table 92. Boehringer Ingelheim Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Boehringer Ingelheim Anticoagulant Reversal Drug Product
    Table 94. Boehringer Ingelheim Recent Developments/Updates
    Table 95. CSL Corporation Information
    Table 96. CSL Description and Business Overview
    Table 97. CSL Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. CSL Anticoagulant Reversal Drug Product
    Table 99. CSL Recent Developments/Updates
    Table 100. Octapharma Corporation Information
    Table 101. Octapharma Description and Business Overview
    Table 102. Octapharma Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Octapharma Anticoagulant Reversal Drug Product
    Table 104. Octapharma Recent Developments/Updates
    Table 105. Portola Pharmaceuticals Corporation Information
    Table 106. Portola Pharmaceuticals Description and Business Overview
    Table 107. Portola Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Portola Pharmaceuticals Anticoagulant Reversal Drug Product
    Table 109. Portola Pharmaceuticals Recent Developments/Updates
    Table 110. Perosphere Pharmaceuticals Corporation Information
    Table 111. Perosphere Pharmaceuticals Description and Business Overview
    Table 112. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product
    Table 114. Perosphere Pharmaceuticals Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Anticoagulant Reversal Drug Distributors List
    Table 118. Anticoagulant Reversal Drug Customers List
    Table 119. Anticoagulant Reversal Drug Market Trends
    Table 120. Anticoagulant Reversal Drug Market Drivers
    Table 121. Anticoagulant Reversal Drug Market Challenges
    Table 122. Anticoagulant Reversal Drug Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anticoagulant Reversal Drug
    Figure 2. Global Anticoagulant Reversal Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anticoagulant Reversal Drug Market Share by Type in 2023 & 2030
    Figure 4. Prothrombin Complex Concentrates Product Picture
    Figure 5. Vitamin K Product Picture
    Figure 6. Protamine Product Picture
    Figure 7. Tranexamic Acid Product Picture
    Figure 8. Global Anticoagulant Reversal Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Anticoagulant Reversal Drug Market Share by Application in 2023 & 2030
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Others
    Figure 13. Global Anticoagulant Reversal Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Anticoagulant Reversal Drug Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Anticoagulant Reversal Drug Sales (2019-2030) & (K Units)
    Figure 16. Global Anticoagulant Reversal Drug Average Price (USD/Unit) & (2019-2030)
    Figure 17. Anticoagulant Reversal Drug Report Years Considered
    Figure 18. Anticoagulant Reversal Drug Sales Share by Manufacturers in 2023
    Figure 19. Global Anticoagulant Reversal Drug Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Anticoagulant Reversal Drug Players: Market Share by Revenue in 2023
    Figure 21. Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Anticoagulant Reversal Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Anticoagulant Reversal Drug Sales Market Share by Country (2019-2030)
    Figure 24. North America Anticoagulant Reversal Drug Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Anticoagulant Reversal Drug Sales Market Share by Country (2019-2030)
    Figure 28. Europe Anticoagulant Reversal Drug Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Anticoagulant Reversal Drug Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Anticoagulant Reversal Drug Revenue Market Share by Region (2019-2030)
    Figure 36. China Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Anticoagulant Reversal Drug Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Anticoagulant Reversal Drug Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Anticoagulant Reversal Drug Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Anticoagulant Reversal Drug Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Anticoagulant Reversal Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Anticoagulant Reversal Drug by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Anticoagulant Reversal Drug by Type (2019-2030)
    Figure 58. Global Anticoagulant Reversal Drug Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Anticoagulant Reversal Drug by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Anticoagulant Reversal Drug by Application (2019-2030)
    Figure 61. Global Anticoagulant Reversal Drug Price (USD/Unit) by Application (2019-2030)
    Figure 62. Anticoagulant Reversal Drug Value Chain
    Figure 63. Anticoagulant Reversal Drug Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS